Q3 2024 · 13F-HR
First Turn Management, LLCholdings as filed
Filed 2024-11-07 · accession 0001085146-24-005432
$631.6M
Reported value
38
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 670703107 | NUVL | NUVALENT INC | $36.7M | 5.82% | 359,114 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $29.5M | 4.67% | 54,440 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $26.0M | 4.12% | 356,451 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $25.3M | 4.00% | 647,611 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $24.2M | 3.84% | 211,985 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $22.9M | 3.63% | 255,294 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $22.9M | 3.62% | 1,187,165 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $22.5M | 3.56% | 150,593 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $19.8M | 3.13% | 155,650 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $18.6M | 2.95% | 254,800 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $18.1M | 2.86% | 353,376 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $17.9M | 2.84% | 114,247 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $17.9M | 2.83% | 214,298 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $16.6M | 2.62% | 178,929 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $16.5M | 2.61% | 572,928 | Common | SOLE |
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $16.4M | 2.59% | 35,222 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $15.8M | 2.50% | 315,816 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $15.4M | 2.45% | 357,003 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $15.4M | 2.44% | 308,014 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $14.9M | 2.35% | 1,451,037 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $14.9M | 2.35% | 30,254 | Common | SOLE |
| 415858109 | HROW | HARROW INC | $14.7M | 2.32% | 326,582 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $14.4M | 2.28% | 326,494 | Common | SOLE |
| 055477103 | BCAX | BICARA THERAPEUTICS INC | $14.3M | 2.27% | 562,391 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $14.2M | 2.25% | 3,124,967 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $13.7M | 2.16% | 535,092 | Common | SOLE |
| 000899104 | ADMA | ADMA BIOLOGICS INC | $13.3M | 2.10% | 664,985 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $13.2M | 2.09% | 947,878 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $13.2M | 2.09% | 88,714 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $12.8M | 2.03% | 325,218 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $12.5M | 1.98% | 96,097 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $12.4M | 1.96% | 67,942 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $11.8M | 1.87% | 223,147 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $11.5M | 1.82% | 621,306 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $10.2M | 1.61% | 399,781 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $8.7M | 1.37% | 1,226,354 | Common | SOLE |
| 82835W108 | SPRY | ARS PHARMACEUTICALS INC | $8.6M | 1.36% | 593,291 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $4.1M | 0.65% | 355,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.